Clinical Trial Update: Azopt (Brinzolamide 1.0%) Plus Travatan (Travoprost 0.004%) in Treating Patients With Chronic Angle-Closure Glaucoma (CACG) [Phase 4]

View source ↗

Summary

A Phase 4 trial investigating azopt (brinzolamide) 1.0% plus travatan (travoprost) 0.004% in chronic angle-closure glaucoma; the study is terminated with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angle-closure Glaucoma

Drugs mentioned

• Azopt (brinzolamide)
• Travatan (travoprost)

Snippet

Sponsor: Alcon Research | Conditions: Intraocular Pressure | Phase 4 | Status: TERMINATED | Results posted: 2010-02-05